Evaluation of Statin Eligibility, Prescribing Practices, and Therapeutic Responses Using ATP III, ACC/AHA, and NLA Dyslipidemia Treatment Guidelines in a Large Urban Cohort of HIV-Infected OutpatientsMatthew E. Levy, David Hardy, Jeffery Binkley et al.|AIDS Patient Care and STDs|2018Cited by 27
Phase I/II trial of thymosin fraction 5 and thymosin alpha one in HTLV-III seropositive subjects.R S Schulof, Sarah B. Schlesselman, Gy. Simon et al.|PubMed|1986Cited by 11
Immunosuppression and HIV Viremia Associated with More Atherogenic Lipid Profile in Older People with HIVMatthew E. Levy, D. A. Hardy, Alan E. Greenberg et al.|AIDS Research and Human Retroviruses|2018Cited by 10